Lorvotuzumab is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine.
Purity:
>99.5%
CAS Number:
[339306-30-8]
* VAT and and shipping costs not included. Errors and price changes excepted